These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1924460)

  • 1. External beam irradiation combined with the use of 192-iridium implants and radiofrequency-induced hyperthermia in the treatment of prostatic carcinoma.
    Bagshaw MA; Prionas SD; Goffinet DR; Cox RS; Kapp DS; Freiha F
    Prog Clin Biol Res; 1991; 370():275-9. PubMed ID: 1924460
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined iridium 192 afterloading therapy of prostate carcinoma].
    Dinges S; Loening SA; Budach V
    Praxis (Bern 1994); 1997 Nov; 86(48):1908-11. PubMed ID: 9480511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iridium-192 implants in patients with large stage C prostate cancer.
    Brosman SA
    Prog Clin Biol Res; 1991; 370():281-90. PubMed ID: 1924461
    [No Abstract]   [Full Text] [Related]  

  • 4. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
    Momma T; Saito S; Toya K; Yorozu A; Dokiya T; Murai M
    Int J Urol; 2006 Mar; 13(3):218-23. PubMed ID: 16643612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.
    Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic carcinosarcoma 15 years after combined external beam radiation and brachytherapy for prostatic adenocarcinoma: a case report.
    Tseng TY; Sevilla DW; Moul JW; Maloney KE
    Prostate Cancer Prostatic Dis; 2006; 9(2):195-7. PubMed ID: 16568146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: a 6-year follow-up.
    Kälkner KM; Wahlgren T; Ryberg M; Cohn-Cedermark G; Castellanos E; Zimmerman R; Nilsson J; Lundell M; Fowler J; Levitt S; Hellström M; Nilsson S
    Acta Oncol; 2007; 46(7):909-17. PubMed ID: 17917823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interstitial Ir-192 afterloading therapy with sequential warm-water hyperthermia].
    Stücklschweiger G; Schad KA; Handl-Zeller L; Leitner H; Poier E; Hackl A
    Strahlenther Onkol; 1991 Feb; 167(2):98-104. PubMed ID: 2000552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.
    Jo Y; Hiratsuka J; Fujii T; Takenaka A; Fujisawa M
    Urology; 2004 Sep; 64(3):556-60. PubMed ID: 15351592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 192Ir low dose rate brachytherapy for boosting locally advanced prostate cancers after external beam radiotherapy: a phase II trial.
    Nickers P; Coppens L; de Leval J; Jansen N; Deneufbourg JM
    Radiother Oncol; 2006 Jun; 79(3):329-34. PubMed ID: 16780976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
    Nickers P; Thissen B; Jansen N; Deneufbourg JM
    Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment.
    Stromberg JS; Martinez AA; Horwitz EM; Gustafson GS; Gonzalez JA; Spencer WF; Brabbins DS; Dmuchowski CF; Hollander JB; Vicini FA
    Cancer J Sci Am; 1997; 3(6):346-52. PubMed ID: 9403047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bax and Bcl-2 protein expression following radiation therapy versus radiation plus thermoradiotherapy in stage IIIB cervical carcinoma.
    Harima Y; Nagata K; Harima K; Oka A; Ostapenko VV; Shikata N; Ohnishi T; Tanaka Y
    Cancer; 2000 Jan; 88(1):132-8. PubMed ID: 10618615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prostatectomy, brachytherapy, percutaneous irradiation. Which method helps your patients the most?].
    Messer PM; Gottfried HW; Hautmann R; Röttinger EM
    MMW Fortschr Med; 2002 Jan; 144(1-2):39-41. PubMed ID: 11847880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0.
    Tilly W; Gellermann J; Graf R; Hildebrandt B; Weissbach L; Budach V; Felix R; Wust P
    Strahlenther Onkol; 2005 Jan; 181(1):35-41. PubMed ID: 15660191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined treatment with 8 MHz radiofrequency hyperthermia and irradiation in a patient with advanced ureteral cancer].
    Nakajima K; Hisazumi H; Nakashima T; Kumaki O; Saito Y; Takashima T
    Gan No Rinsho; 1986 Jan; 32(1):101-5. PubMed ID: 3951122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction chemotherapy and radiotherapy to avoid mastectomy in stage IIA-IIIA breast cancer.
    Hartmann KA; Waap I; Audretsch W; Muskalla K; Rezai M; von der Haar J; Schmitt G
    Oncol Rep; 1998; 5(2):503-6. PubMed ID: 9468589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Place of iridium 192 implantation in irradiation of T1-T2 squamous cell carcinoma of the velopharyngeal arch].
    Mazeron JJ; Belkacemi Y; Simon JM; Le Péchoux C; Martin M; Haddad E; Piedbois P; Calitchi E; Strunski W; Peynègre R; Le Bourgeois JP; Pierquin B
    Bull Cancer Radiother; 1996; 83(1):47-53. PubMed ID: 8679281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermometry of interstitial hyperthermia given as an adjuvant to brachytherapy for the treatment of carcinoma of the prostate.
    Prionas SD; Kapp DS; Goffinet DR; Ben-Yosef R; Fessenden P; Bagshaw MA
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):151-62. PubMed ID: 8270436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.